Our animal experiments suggested that HFLD reduced oxidative stress and ameliorated atrial pathological damage, thereby reducing AF susceptibility probably by regulating the NOX2–ROS–TGF-β1 pathway. This evidence concerns the gene TGFB1 and atrial fibrillation.